Detail page

Knowledge Web

Person

Beiping Miao

Name	Beiping Miao
Time	2020- (Wirkungsdaten)
Place	Jiangsu (Geburtsort) China Deutschland
Gender	männlich
Academic degree	Dr. sc. hum. (an der Medizinischen Fakultät Heidelberg der Ruprecht-Karls-Universität) (2020)
Variant	Miao Beiping Miao Beiping
Related	Deutsches Krebsforschungszentrum Universität Heidelberg Tiermedizin (Studienfach) Präventive Tiermedizin (Master) (Studienfach) Biologie (Bachelor) (Studienfach)
Record type	Person
GND-Identifier	1199379204
Record ID	1199379204
Involved in show all Germline variants of CYBA and TRPM4 predispose to familial colorectal cancer Whole-exome sequencing identifies a novel germline variant in PTK7 gene in familial colorectal cancer A novel low-risk germline variant in the SH2 domain of the SRC gene affects multiple pathways in familial colorectal cancer Whole exome sequencing identifies APCDD1 and HDAC5 genes as potentially cancer predisposing in familial colorectal cancer The E-twenty-six transcription factor FLI-1 promotes cell cycle progression in cancer by regulation hTERT-CCND1 Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Beiping Miao

Germline variants of CYBA and TRPM4 predispose to familial colorectal cancer

Whole-exome sequencing identifies a novel germline variant in PTK7 gene in familial colorectal cancer

A novel low-risk germline variant in the SH2 domain of the SRC gene affects multiple pathways in familial colorectal cancer

Whole exome sequencing identifies APCDD1 and HDAC5 genes as potentially cancer predisposing in familial colorectal cancer

The E-twenty-six transcription factor FLI-1 promotes cell cycle progression in cancer by regulation hTERT-CCND1

Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression